Monitoring of pharmaceutically active compounds on the Guadalquivir River basin (Spain): occurrence and risk assessment.
about
Estrogenic compounds in Tunisian urban sewage treatment plant: occurrence, removal and ecotoxicological impact of sewage discharge and sludge disposal.Determination of the Presence of Three Antimicrobials in Surface Water Collected from Urban and Rural Areas.Detection of veterinary drug residues in surface waters collected nearby farming areas in Galicia, North of Spain.Monitoring the presence of 13 active compounds in surface water collected from rural areas in northwestern Spain.Monitoring of emerging pollutants in Guadiamar River basin (South of Spain): analytical method, spatial distribution and environmental risk assessment.Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.Pollution in mediterranean-climate rivers
P2860
Q36142130-34A9530D-EC7F-439B-BDA5-89BAD43F5197Q38976472-D55ED889-3C4E-4704-A9D3-3AED39ADB165Q40139770-05A96FF0-3188-48A1-A947-E33016D044F6Q40191997-64281B10-62B8-4CD4-8D37-8BA2167D8277Q40408566-2280471D-E011-4266-A2A8-9EC4D3F3577DQ46357509-98B62DD0-50ED-4783-95D1-561BF783B00CQ57237595-BBB73691-D59D-4699-A0C9-3711DF11FDAC
P2860
Monitoring of pharmaceutically active compounds on the Guadalquivir River basin (Spain): occurrence and risk assessment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Monitoring of pharmaceutically ...... ccurrence and risk assessment.
@en
Monitoring of pharmaceutically active compounds on the Guadalquivir River basin
@nl
type
label
Monitoring of pharmaceutically ...... ccurrence and risk assessment.
@en
Monitoring of pharmaceutically active compounds on the Guadalquivir River basin
@nl
prefLabel
Monitoring of pharmaceutically ...... ccurrence and risk assessment.
@en
Monitoring of pharmaceutically active compounds on the Guadalquivir River basin
@nl
P2093
P2860
P356
P1476
Monitoring of pharmaceutically ...... ccurrence and risk assessment.
@en
P2093
D Camacho-Muñoz
I Aparicio
J L Santos
P2860
P304
P356
10.1039/C1EM10185D
P577
2011-06-13T00:00:00Z